The scientific literature has extensively documented miR-26a-5p and miR-26b-5p identified in Table 1 as potential regulators of s-DAPK-1 for their tumor-suppressing activities in hepatocellular carcinoma and gastric cancer, respectively [42,43,44]. Here, DAPK1 is linked to neoplasm.